Whitney Daniel G, Schmidt Mary, Bell Sarah, Morgenstern Hal, Hirth Richard A
Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI, USA.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
Clin Epidemiol. 2020 Feb 27;12:235-243. doi: 10.2147/CLEP.S242264. eCollection 2020.
Due to complex medical profiles, adults with neurodevelopmental disabilities (NDDs) may have a heightened risk for early development of chronic kidney disease (CKD) and accelerated CKD progression to advanced stages and kidney failure. The purpose of this study was to estimate the incidence rate of advanced CKD for adults with NDDs and compare the incidence rate to adults without NDDs.
Data were used from the Optum Clinformatics Data Mart to conduct this retrospective cohort study. The calendar year 2013 was used to identify eligible participants: individuals ≥18 years of age and without advanced CKD. Participants were followed from 01/01/2014 to advanced CKD, loss to follow-up, death, or end of the study period (12/31/2017), whichever came first. Diagnostic, procedure, and diagnosis-related group codes identified NDDs (intellectual disabilities, cerebral palsy, autism spectrum disorders), incident cases of advanced CKD (CKD stages 4+), diabetes, cardiovascular diseases, and hypertension present in the year 2013. Crude incidence rates (IR) of advanced CKD and IR ratios (IRR), comparing adults with vs without NDDs (with 95% CI) were estimated. Then, Cox regression estimated the hazard ratio (HR and 95% CI) for advanced CKD, comparing adults with NDDs to adults without NDDs while adjusting for covariates.
Adults with NDDs (n=33,561) had greater crude IR of advanced CKD (IRR=1.32; 95% CI=1.24-1.42) compared to adults without NDDs (n=6.5M). The elevated rate of advanced CKD among adults with NDDs increased after adjusting for demographics (HR=2.19; 95% CI=2.04-2.34) and remained elevated with further adjustment for hypertension and diabetes (HR=2.01; 95% CI=1.87-2.15) plus cardiovascular disease (HR=1.84; 95% CI=1.72-1.97). Stratified analyses showed that the risk of advanced CKD was greater for all NDD subgroups.
Study findings suggest that adults with NDDs have a greater risk of advanced CKD than do adults without NDDs, and that difference is not explained by covariates used in our analysis.
由于复杂的医学状况,患有神经发育障碍(NDDs)的成年人可能患慢性肾脏病(CKD)早期发展以及CKD加速进展至晚期和肾衰竭的风险更高。本研究的目的是估计患有NDDs的成年人晚期CKD的发病率,并将该发病率与没有NDDs的成年人进行比较。
使用Optum临床信息数据集市的数据进行这项回顾性队列研究。2013年用于确定符合条件的参与者:年龄≥18岁且无晚期CKD的个体。参与者从2014年1月1日开始随访,直至出现晚期CKD、失访、死亡或研究期结束(2017年12月31日),以先发生者为准。诊断、手术和诊断相关组代码确定了2013年存在的NDDs(智力残疾、脑瘫、自闭症谱系障碍)、晚期CKD(CKD 4期及以上)、糖尿病、心血管疾病和高血压的发病病例。估计了晚期CKD的粗发病率(IR)以及患有与未患有NDDs的成年人之间的IR比(IRR)(95%CI)。然后,Cox回归估计了患有NDDs的成年人与未患有NDDs的成年人相比晚期CKD的风险比(HR和95%CI),同时对协变量进行了调整。
与没有NDDs的成年人(n = 650万)相比,患有NDDs的成年人(n = 33561)晚期CKD的粗IR更高(IRR = 1.32;95%CI = 1.24 - 1.42)。在对人口统计学进行调整后,患有NDDs的成年人中晚期CKD的升高率仍然存在(HR = 2.19;95%CI = 2.04 - 2.34),在进一步对高血压和糖尿病进行调整后(HR = 2.01;95%CI = 1.87 - 2.15)以及加上心血管疾病后(HR = 1.84;95%CI = 1.72 - 1.97)仍然升高。分层分析表明,所有NDD亚组晚期CKD的风险都更高。
研究结果表明,患有NDDs的成年人比没有NDDs的成年人患晚期CKD的风险更大,并且这种差异无法用我们分析中使用的协变量来解释。